How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
Official title: Does Chronic Pain Change Over Time in Children With Duchenne Muscular Dystrophy?
Run by Antalya Training and Research Hospital · NCT07892196 · Data updated 2026-11-12
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 18 Years |
| Sex | Men only |
| Enrollment | 30 (estimated) |
| Sponsor | Antalya Training and Research Hospital Government |
| Locations | 1 site (Antalya, Antalya) |
| Status | Recruiting |
| Started | January 2, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07892196 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 7-18 with genetically confirmed Duchenne Muscular Dystrophy, residing in Antalya, Turkey, and able to complete self-report assessments.
✕Probably not a fit
Patients who are bedridden, have severe communication impairments, or do not reside in Antalya may have limited relevance to the study outcomes.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective observational study of pediatric DMD patients aged 7-18. Participants will be assessed at baseline and after 6 months for chronic pain, pain characteristics, coping strategies, and functional performance. Pain will be measured with the Adolescent Pediatric Pain Tool and the Brief Pain Inventory, while coping will be evaluated using the Pediatric Pain Coping Inventory; comparisons will be made between ambulatory and non-ambulatory patients. The study aims to describe how pain prevalence, distribution, duration, and impact differ by disease stage and to explore associated coping mechanisms. The setting is the Neuromuscular Diseases Center at Antalya Training and Research Hospital, with geographic limits to Antalya residents to minimize follow-up loss.
Why it matters
Potential benefit: Findings could help clinicians tailor pain management and improve quality of life for children with DMD at different disease stages.
How similar studies have gone: Prior research in DMD and pediatric pain suggests pain is common and variable by function, but this specific 6-month prospective approach in Antalya is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Genetically confirmed diagnosis of Duchenne Muscular Dystrophy (DMD) * Aged 7 to 18 years * Residing in Antalya, Turkey (geographical restriction applied to minimize patient travel burden and prevent loss to follow-up over the 6-month observation period) * Intact hearing and vision capability sufficient to complete test instructions and self-report forms * Voluntary willingness to participate, with signed informed consent from parents/legal guardians and informed assent from the child Exclusion Criteria: * Bedridden status (inability to sit or maintain basic seated posture) * History of tracheostomy * Severe intellectual disability that precludes understanding instructions * Severe speech or communication impairment preventing self-report assessments * Presence of co-existing psychiatric or neurodevelopmental conditions (e.g., autism spectrum disorder, attention deficit hyperactivity disorder \[ADHD\])
Where it's running
-
University of Health Sciences Antalya Training and Research Hospital, Neuromuscular Diseases Center
Antalya, Antalya, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: beyza deveci, MD — +90 242 249 44 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Zeleciment Rostudirsen (DYNE-251) for Duchenne Muscular Dystrophy in Ambulatory Boys
This trial tests whether intravenous Zeleciment Rostudirsen (DYNE-251) given every 4 weeks is safe and helps improve function in ambulatory boys with Duchenne muscular dystrophy who have a specific dystrophin gene mutation.
-
Use of invasive home ventilation in Denmark
This project will see how often people with neuromuscular diseases or spinal cord injuries in Denmark used invasive home mechanical ventilation between 2016 and 2025 and what their one-year outcomes were.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.